user

Efficacy and safety of nab-paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment for patients with advanced gastric cancer: A single institutional experience

被引：0
|
作者：
Okunaka, Mashiro
Kotani, Daisuke
Demachi, Ken
Kawazoe, Akihito
Yoshino, Takayuki
Shitara, Kohei
机构：
[1] Natl Canc Ctr Hosp East, Dept Pharm, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr Hosp East, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
322
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [2] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    Investigational New Drugs, 2020, 38 : 533 - 540
  • [3] Comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as 2nd-line treatment for gastric cancer
    Tsuji, Kunihiro
    Miyajima, Saori
    Kito, Yosuke
    Doyama, Hisashi
    ANNALS OF ONCOLOGY, 2021, 32 : S330 - S330
  • [4] Nab-paclitaxel plus ramucirumab combination therapy as second-line with advanced gastric cancer:Retrospective study
    Kashiwada, Tomomi
    Nishioka, Atsujiro
    Komiya, Kazutoshi
    Aragane, Naoko
    Kimura, Shinya
    ANNALS OF ONCOLOGY, 2019, 30 : 140 - 140
  • [5] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Mashiro Okunaka
    Daisuke Kotani
    Ken Demachi
    Akihito Kawazoe
    Takayuki Yoshino
    Toshikatsu Kawasaki
    Kohei Shitara
    BMC Cancer, 20
  • [6] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Kawasaki, Toshikatsu
    Shitara, Kohei
    BMC CANCER, 2020, 20 (01)
  • [7] A phase II study of nab-paclitaxel plus ramucirumab for the second-line treatment of patients with metastatic gastroesophageal cancer
    Bendell, Johanna C.
    Percent, Ivor John
    Weaver, Robert Waide
    Chua, Cynthia Coo
    Xiong, Henry Q.
    Cohn, Allen Lee
    Zakari, Ahmed
    Singh, Jaswinder
    Kozloff, Mark
    Lietman, Caressa
    Lane, Cassie Michelle
    Jones, Suzanne Fields
    Finney, Lindsey H.
    Carmody, Sean
    Womack, Mark Sanders
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] Ramucirumab plus paclitaxel as a second-line treatment for advanced gastric or gastro-oesophageal junction cancer
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 (11) : 642 - 642
  • [9] Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Egashira, Akinori
    Sonoda, Hideto
    Hashimoto, Kenkichi
    Uehara, Hideo
    Kusumoto, Eiji
    Shinzato, Chiaki
    Uchino, Keita
    Sakaguchi, Yoshihisa
    Ikejiri, Koji
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Efficacy and Safety of Ramucirumab/nab-paclitaxel for Previously Treated Advanced Gastric Cancer in Community Hospitals
    Hashida, Shinsuke
    Tanaka, Norimitsu
    Takahashi, Yuta
    Onoda, Yuji
    Colvin, Hugh Shunsuke
    Ohashi, Ryuichiro
    Okamoto, Kunio
    ACTA MEDICA OKAYAMA, 2021, 75 (02) : 133 - 138
12345